Role Overview
The Director of PET Manufacturing, External Network is responsible for developing and leading a robust external manufacturing network for positron emission tomography (PET) radiopharmaceuticals, building strategic partnerships with contract manufacturing organizations, hospital-based radiopharmacies, academic production sites, and commercial PET manufacturing providers to ensure reliable, compliant, and scalable supply.
About Fusion pharmaceuticals
Fusion Pharmaceuticals, part of the AstraZeneca Group, is redefining precision oncology with next-generation radioconjugates that deliver powerful alpha-emitting payloads directly to tumors. Our pipeline spans multiple first-in-class programs-backed by a GMP-compliant, state-of-the-art radiopharmaceutical facility in Hamilton, we're turning cutting